Status:

RECRUITING

Cancer Risk Assessment in Patients With a Constitutional Alteration of the PTEN Gene

Lead Sponsor:

Institut Bergonié

Conditions:

PTEN Gene Mutation

Eligibility:

All Genders

Brief Summary

This is a multicentric, observational, retrospective and prospective study, aiming to estimate the risk of cancer occurrence in subjects carrying a PTEN mutation, based on the constitution of a nation...

Detailed Description

After collection of the non objection and verification of the eligibility criteria, a first clinical questionnaire will be completed by the participant and the prescribing physician to collect the mai...

Eligibility Criteria

Inclusion Criteria:

  1. Male or female.
  2. Adult or child without age limit.
  3. Carrier of a constitutional or mosaic alteration of the PTEN gene established and/or confirmed by the Institut Bergonié's genetics laboratory, following a request for molecular diagnosis made between 1997 and 2027.
  4. Participant informed of his genetic diagnosis.
  5. Participant informed and not having expressed non-opposition to participate in the research.
  6. Participant affiliated to a French social security system in accordance with French law on research involving the human person.

Exclusion Criteria:

  1. Participant under guardianship or curatorship. Exception: a participant with autism may be included in the study.
  2. Persons deprived of their liberty by a judicial or administrative decision.
  3. Persons under psychiatric care, persons admitted to a health or social establishment for purposes other than research; Exception: a participant with autism may be included in the study.

Key Trial Info

Start Date :

June 12 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 1 2048

Estimated Enrollment :

430 Patients enrolled

Trial Details

Trial ID

NCT05630105

Start Date

June 12 2023

End Date

January 1 2048

Last Update

December 2 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institut Bergonié, Comprehensive Cancer Center

Bordeaux, France

Cancer Risk Assessment in Patients With a Constitutional Alteration of the PTEN Gene | DecenTrialz